Pustular Psoriasis
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP (NCT05215561) | Novartis Pharmaceuticals | 2022-02-14 |
| Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) (NCT03885089) | Pfizer | 2019-10-21 |
| An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis (NCT02343744) | Janssen Pharmaceutical K.K. | 2015-01-19 |
| Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases (NCT01952275) | University of Zurich | 2014-01-01 |
| Anakinra for Inflammatory Pustular Skin Diseases (NCT01794117) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2013-07-22 |
Track Pustular Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.